Intec Pharma (NTEC) Receives Daily Media Impact Rating of 0.56

News articles about Intec Pharma (NASDAQ:NTEC) have been trending very positive recently, according to AlphaOne. The research firm, a division of Accern, identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Intec Pharma earned a media sentiment score of 0.56 on AlphaOne’s scale. AlphaOne also assigned media headlines about the biotechnology company an impact score of 0 out of 100, meaning that recent press coverage is extremely unlikely to have an effect on the company’s share price in the near term.

Intec Pharma (NASDAQ NTEC) opened at 5.65 on Monday. The firm’s 50-day moving average price is $5.39 and its 200 day moving average price is $5.17. Intec Pharma has a one year low of $4.14 and a one year high of $6.36. The firm’s market cap is $77.61 million.

Several equities analysts have commented on the company. Maxim Group set a $9.00 price target on Intec Pharma and gave the company a “buy” rating in a report on Wednesday, May 24th. Zacks Investment Research downgraded Intec Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, May 24th.

ILLEGAL ACTIVITY NOTICE: “Intec Pharma (NTEC) Receives Daily Media Impact Rating of 0.56” was first reported by Mideast Time and is owned by of Mideast Time. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.mideasttime.com/intec-pharma-ntec-receives-daily-media-impact-rating-of-0-56/1751880.html.

Intec Pharma Company Profile

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:NTEC”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Intec Pharma Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intec Pharma Ltd and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.